| 2024/05/20 12:43:37 | |
|---|---|
| Price | |
| 0.817 EUR | |
| Difference | 0.99% (0.01) |
General attributes
| ISIN | NL00150002Q7 |
| Symbol | VVY |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 21 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | 0.818 EUR (3,800) |
| Ask (Ask size) | 0.829 EUR (3,800) |
| Open | 0.82 EUR |
| High | 0.829 EUR |
| Low | 0.817 EUR |
| Close (prev. day) | 0.809 EUR |
| VWAP | 0.82301 EUR |
| Volume (pcs) | 3,820 |
| Trading volume | 3,143.90 |
| Number of trades | 6 |
| Last size | 30 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: VIVORYON THERAPEUTICS AG |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/05/20 12:43:37 | |
|---|---|
| Price | |
| 0.817 EUR | |
| Difference | 0.99% (0.01) |
General attributes
| ISIN | NL00150002Q7 |
| Symbol | VVY |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 21 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | 0.818 EUR (3,800) |
| Ask (Ask size) | 0.829 EUR (3,800) |
| Open | 0.82 EUR |
| High | 0.829 EUR |
| Low | 0.817 EUR |
| Close (prev. day) | 0.809 EUR |
| VWAP | 0.82301 EUR |
| Volume (pcs) | 3,820 |
| Trading volume | 3,143.90 |
| Number of trades | 6 |
| Last size | 30 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -89.52% | -94.75% | -93.91% |
| Perf (abs.) | -6.91 | -14.59 | -12.47 |
| Beta | 3.33 | 2.02 | 1.24 |
| Volatility | 364.71 | 256.69 | 157.05 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 0.769 EUR (11,714) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 0.667 EUR (66,159) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 4.447 EUR (134,923) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 8.386 EUR (56,311) |
| YTD High | date | 9.990 EUR (2024/02/19) |
| YTD Low | date | 0.421 EUR (2024/04/17) |
| 52 Weeks High | date | 16.380 EUR (2023/05/26) |
| 52 Weeks Low | date | 0.421 EUR (2024/04/17) |
All listings for VIVORYON THERAPEUTICS AG
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/05/20 | 12:43 | 0.817 EUR | 0.00 | 6 |
| Stuttgart | 2024/05/20 | 14:28 | 0.812 EUR | 0.00 | 5 |
| Munich | 2024/05/20 | 08:10 | 0.798 EUR | 0.00 | 1 |
| London Stock Exchange | 2024/02/02 | 16:10 | 8.313 EUR | 0.02 | 1 |
| Frankfurt | 2024/05/20 | 08:20 | 0.778 EUR | 0.00 | 1 |
| Euronext Amsterdam | 2024/05/20 | 15:20 | 0.821 EUR | 0.16 | 146 |
| Duesseldorf | 2024/05/20 | 08:11 | 0.818 EUR | 0.00 | 1 |
| Berlin | 2024/05/20 | 14:15 | 0.822 EUR | 0.00 | 9 |
Company Logo
Contact Details
| VIVORYON THERAPEUTICS NV |
| - - |
| Weinbergweg 22 - 06120 Halle |
| Telefon: +49-345-555-99-00 |
| Fax: + |
| E-mail: info@vivoryon.com |
PDF Downloads
| Company report: VIVORYON THERAPEUTICS AG | |
Company Profile
Vivoryon Therapeutics NV is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany. |
Members of Management Board
| Frank Weber | Chairman of Managing Board |
| Michael Schaeffer | Member of Executive Committee |
| Anne Doering | Member of Executive Committee |
| Florian Schmid | Member of Executive Committee |
Board of directors
| Erich Maximilian Platzer | Chairman of Supervisory Board |
| Claudia Riedl | Member of Supervisory Board |
| Michael Schaeffer | Member of Supervisory Board |
| Samir Shah | Member of Supervisory Board |
| Anne Doering | Member of Supervisory Board |
| Charlotte Lohmann | Member of Supervisory Board |